In the present study, we have investigated the mechanisms by which the restoration of wild -type ( wt ) p53 functions in p53 mutant cells increases their susceptibility to the cytotoxic action of tumor necrosis factor ( TNF ). Our data indicate that the resistance of p53 -mutated cl.1001 cells to TNF -induced cell death was not due to a defect in the expression of TRADD and FADD, yet correlated with a reduced caspase -8 activation as well as a deficient mitochondrial membrane permeabilization. Moreover, cl.1001 cells failed to translocate the mitochondrial AIF and cytochrome c to the nucleus and to the cytosol, respectively, in response to TNF. Sensitization of these cells, following infection with a recombinant adenovirus encoding wtp53, to TNF -induced cytotoxicity resulted in the restoration of caspase -8 cleavage and the reestablishment of mitochondrial signs of apoptosis. These findings suggest that the crosstalk between p53 and TNF -induced cell death depends on mitochondria and that the combination of TNF and Adwtp53 may be a potential strategy to sensitize mutant p53 TNF -resistant tumors to the cytotoxic action of this cytokine.
T umor necrosis factor (TNF ) is a pleiotropic cytokine that elicits a wide variety of functions and plays a determinant role in the immune and antitumor response. 1 -3 However, despite the major advance in understanding the early events in TNF signaling and the identification of molecules that are recruited to TNFR1, the mechanisms of resistance to the cytotoxic action of TNF remain largely unknown. Therefore, understanding the molecular and biochemical mechanisms of tumor cell resistance to the cytocidal action of this cytokine and its attenuation may ultimately provide new approaches to enhance its therapeutic efficacy against human malignancies.
It has become clear that the initiation of intracellular signaling events through TNFR1 depends on cytosolic adapter and effector proteins recruited to the receptor complex ( death -inducing signaling complex ). 4 Among these molecules, TRADD (TNFR1-associated death domain) specifically interacts with TNFR1 via its death domain motif. 5 TRADD is also able to directly interact with FADD ( Fas -associated death domain ) to induce apoptosis and with TRAF2 ( TNF receptor-associated factor 2 ) and RIP (Receptor Interacting Protein ) to activate NF -B and SAPK / JNK pathways. 6, 7 FADD couples the TNFR1-TRADD complex to activation of caspase-8 by recruiting pro -caspase -8 to the receptor complex. The recruitment of pro -caspase -8 ultimately results in the proteolytical ( auto -) activation of caspase-8 and the subsequent initiation of the apoptotic signaling cascade. 8 -10 This activation of downstream effector caspases ( in particular caspase-3) may either result from the direct caspase -8 -mediated cleavage of caspase -3 (in so-called ''type 1'' cells ) or may involve an obligatory mitochondrial membrane permeabilization event that provides an indirect link between caspase -8 and caspase -3 activation (in so-called ''type 2'' cells ). 11 We and others have recently demonstrated that mitochondria membrane permeabilization frequently exerts essential role in the irreversible commitment of cells to death. 12, 13 The cytotoxicity of TNF has been shown to depend on disruption of the mitochondrial transmembrane potential ( ÁÉ m ) in many cell types and to involve the translocation of cytochrome c to the cytosol. 14 -21 By analogy to other apoptosis inducers, it may be plausible that TNF -induced apoptosis would also be accompanied by the mitochondrial release of apoptosis -inducing factor (AIF ), a caspaseindependent death effector that translocates to the nucleus and participates in the initial chromatin condensation / degradation step. 22 -25 However, the relationship between tumor resistance to the cytotoxic action of TNF and apoptosis -associated parameters of mitochondrial dysfunction is not established. Loss of function mutations of p53 lead to defects in apoptosis, cell cycle arrest, and DNA repair, all of which cause an increase in genomic instability. 26 -29 Wild -type ( wt), but not mutant, p53 induces transcriptional activation of target genes containing p53 -binding sites. Recently, we have shown that the resistance of human breast adenocarcinoma cell line MCF7 to the cytotoxic action of TNF was associated with the loss of p53 function. 30 Moreover, we have demonstrated that the transfer of wtp53 using an adenoviral vector ( Adwtp53) reestablishes TNF sensitivity in TNF -resistant cells. 31 In the present study, we investigated the mechanisms of the p53 -mediated restoration of TNF sensitivity. It appears that the p53 effect involves the reestablishment of the TNF -mediated proapoptotic signal transduction cascade, including the activation of caspase -8 and mitochondrial membrane permeabilization.
Materials and methods

Cell lines and culture
MCF7 TNF -resistant cells, cl.1001, were derived from RA -1 cells transfected by p55 TNFR cDNA as described.
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MCF7 FADD dominant -negative ( DN ) cells were kindly provided by V Dixit (University of Michigan Medical School, Michigan ). All cell lines were routinely cultured in RPMI 1640 medium containing 5% fetal calf serum, 1% penicillin -streptomycin, 1% L -glutamine at 378C in a humidified atmosphere with 5% CO 2 .
Construction of recombinant adenovirus vector expressing wtp53 ( Adwtp53 ) and expression of functional p53
Adwtp53 was produced by in vivo homologous recombination in 293 cells as described. 31 Efficiency of Adwtp53 to transfer and direct expression of wtp53 was analysed on p53 -negative SAOS cells using specific monoclonal antibody 36 hours after infection with Adwtp53. The expression of functional p53 in Adwtp53-infected cells was then analysed using the p53 functional assay in yeast as described. 33 
Cytofluorometric analysis
Cells, 3Â10 5 , either infected with Adwtp53 or control adenovirus and treated with TNF ( 100 ng/ mL ) and /or ZVAD -fmk ( 100 M) for 40 hours, were exposed for 15 minutes at 378C to the following fluorochromes: 3,3 0 -dihexyloxacarbocyanideiodide [DIOC 6 ( 3), 40 nM ] (Molecular Probes, Leiden, Netherlands ) for ÁÉ m quantifications and hydroethidine ( HE, 2 M) ( Molecular Probes ) for the determination of superoxide anion generation. Cells were then analysed in an EPICS II cytofluorometer.
Confocal scanning immunofluorescence microcopy
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5 cultured cells grown on sterile slides were subjected to infection with Adwtp53 or control virus as described above. Slides were washed with PBS and fixed for 10 minutes in 4% PFA. After three washes with PBS, cells were incubated for 20 minutes with 10% blocking serum. After washing with PBS, cells were incubated for 60 minutes either with anti -AIF serum rabbit antibody or with monoclonal anti -cytochrome c. After three washings with PBS, cells were incubated with secondary antibodies coupled either with FITC or PE for 60 minutes. Cells were washed three times and nuclei were stained with Hoechst 33342 for 10 minutes as described. 24, 25 Confocal microscopy was performed on a Leica TC -SP ( Leica Microsystems, Heidelberg, Germany ) equipped with an ArKr laser and an Ar laser mounted on an inverted Leica DM IFBE microscope with an UV 100Â1.4 NA oil objective.
Western blotting
Twenty to 40 g of total cell lysates were separated on SDS polyacrylamide gels and electroblotted onto Hybond 2 membranes (Amersham, Saclay, France ). After blocking, the membranes were probed with anti -TRADD polyclonal antibody (1 /500 ) (Santa Cruz Biotech, Santa Cruz, CA ), anti-FADD ( 1/ 1000 ), anti -caspase -8 (1 /1000 ), and anti -C15 monoclonal antibodies (Immunotech, Marseille, France and Marcus E Peter gift ) and anti -actin monoclonal antibody (1 /3000 ) ( Sigma, Saint Quentin Fallavier, France ). The complexes were detected using the enhanced chemiluminescence detection kit (Amersham ).
Adenovirus infection of cells and determination of cell viability
Cells were seeded in 96 -well plates (7.5Â10 4 cells / mL ), and treated either with human recombinant TNF -(100 ng/mL ) ( specific activity 6.63Â10 6 U / mg protein ), ZVAD -fmk ( 100 M) (Bachem , Voisins-le-Bretonneux, France), or infected with Adwtp53 or control Ad ( 25-200 pfu ), in the presence or absence of TNF (100 ng/ mL ) or ZVAD -fmk ( 100 M ). After incubation for 40 hours at 378C, the medium was replaced with 0.5% crystal violet solution. Plates were incubated for 10 minutes at room temperature, washed, and viable crystal violet -stained cells were lysed with 1% SDS. Absorbance (A ), which was proportional to cell viability, was then measured at a wavelength of 540 nm. TNF --mediated cell lysis was assessed by comparing the viability of untreated cells with that of treated cells using the following calculation: cell viability ( %)= 100Â(A 1 /A 0 ); cell lysis (% )= 1À cell viability (% ), where A 1 and A 0 are the absorbance obtained from treated and untreated cells, respectively.
Results
TRADD and FADD expression in TNF -resistant cl.1001 cells
Clone 1001 is a TNF -resistant cell line selected from the TNF -sensitive MCF cell line by prolonged culture in the presence of increasing concentrations of TNF. 34 Because TRADD serves primarily as a linker between TNFRI and multiple downstream signaling pathways, including FADD, we asked whether the adaptor proteins TRADD and FADD were normally expressed in the TNF -resistant cl.1001 cells. Immunoblot analyses revealed a similar expression level of TRADD ( 34 kDa ) and FADD ( 23 kDa ) proteins in cl.1001 cells, compared to the parental MCF7 cells (Fig 1A ) . These data indicate that neither TRADD nor FADD defects may explain the TNF resistance in this cell model.
Failure of TNF to induce pro -caspase -8 cleavage in TNF -resistant cells
The recruitment of the pro -caspase -8 to the receptor complex TNFR1 -TRADD -FADD, and its subsequent cleavage and activation, are generally thought to initiate the apoptotic cascade. 4 We examined the status of the two active isoforms a and b of caspase -8, 35 before and after TNF treatment of MCF7 cells and cl.1001. Data depicted in Figure 1B indicate that although the two isoforms (corresponding to the bands of 53 and 55 kDa ) were equally expressed, TNF treatment (100 ng/ mL ) resulted in the generation of cleaved intermediate products of 43 and 41 kDa, ( corresponding to caspases -8 a and b isoforms, respectively ), only in TNF -sensitive MCF7 cells. No such cleavage did occur in TNF -resistant cl.1001 cells ( Fig 1B ) , suggesting that resistance to the cytotoxic action of TNF correlates with an alteration of the upstream initiator caspase -8.
Impairment of mitochondrial permeability transition and reactive oxygen species ( ROS ) generation in TNF -resistant cells
Previous studies have shown that death receptors can use the mitochondria to amplify apoptotic signals.
11,36 To determine the possible involvement of mitochondria in the acquisition of tumor resistance to TNF -induced cell death, cells were incubated for various times with TNF (100 ng / mL ) and subjected to cytofluorometric analysis after staining with DIOC 6 (3 ) and HE (Fig 2A ) . DIOC 6 (3) is a cationic lipophilic used to measure variations in the mitochondrial transmembrane potential (ÁÉ m ). Cells undergoing apoptosis show a reduction in the incorporation of DIOC 6 (3 ), indicating a fall in the ÁÉ m . The generation of ROS was visualised by means of HE, a nonfluorescent agent that is oxidized by ROS to become the fluorescent dye, ethidium (Eth ). 37 Data depicted in Figure 2 indicate that TNF treatment of MCF7 cells induced a disruption in ÁÉ m and generation of ROS in MCF7 cells. In contrast, neither a significant dissipation of ÁÉ m nor the generation of ROS was detected in cl.1001 cells (Fig 2B ) . These results suggest that TNF resistance also involves a defect in proapoptotic signaling at the mitochondrial (or premitochondrial ) level.
Dissipation of ÁÉ m and generation of ROS are caspase -8 -dependent
Accumulating evidence suggests that caspase -8 activation may occur either upstream or downstream of mitochondria, depending on the apoptosis -initiating stimuli. 38 -40 To determine whether caspase -8 activation occurs upstream of mitochondria, MCF7 cells were stably transfected with a DN -FADD construct and the effect of DN -FADD on mitochondrial alterations induced by TNF was assessed. DN -FADD completely inhibited the TNF -triggered ÁÉ m dissipation and ROS generation (Fig 3A ) . Similarly, inhibition of caspase-8 using the pancaspase inhibitor ZVAD -fmk completely blocked both cell death and the mitochondrial alterations. To further determine the temporal relationship between caspase -8 activation and dissipation of ÁÉ m , TNF -treated MCF7 cells were sorted on a cytofluorometer according to their DIOC 6 ( 3) incorporation. The DIOC 6 (3) low and DIOC 6 (3) high cell populations were then subjected to immunoblot analysis in order to investigate caspase -8 activation status. Immunodetectable pro -caspase -8 ( 50 kDa ) completely disappeared in the DIO-C 6 (3) low cell population. In contrast, the pro -caspase -8 levels of DIOC 6 (3) high cells were comparable to those of nontreated cells ( Fig 3B ) . These results suggest that caspase -8 activation and mitochondria are strictly connected, yet the ÁÉ m fall and concomitant ROS generation correlated with the initial caspase activation.
Infection of cl.1001 cells with Adwtp53 induced pro -caspase -8 cleavage and restored TNF -triggered mitochondrial alterations. TNF sensitivity /resistance appears to correlate with caspase -8 activation and mitochondrial alterations, as We therefore wondered whether Adwtp53 would affect the caspase -8 activation status and/ or mitochondria. Adwtp53 infection of cl.1001 cells alone had no effect on the intensity of the band corresponding to the pro -caspase-8 (Fig 4A ) . In presence of TNF, such infection resulted in caspase-8 activation ( 85% at 100 pfu and 92% at 200 pfu decrease in pro -caspase -8 level, respectively ) ( Fig 4B) . The data depicted in Figure 4A indicated that ZVAD -fmk efficiently inhibit caspase activation at 100 pfu ( 100% inhibition ), while having a partial inhibitory effect ( 50% inhibition ) following infection with Adwtp53 (200 pfu ). ( 100 ng / mL ) for 36 hours or with TNF plus ZVAD -fmk ( 100 M ) ( for MCF7 cells ). Cells were trypsinized, washed with PBS, and incubated with DIOC 6 ( 3 ) and HE for 15 minutes at 378C. Cells were then subjected to cytofluorometric analysis. One representative experiment out of six is shown. B: Cells were treated with TNF ( 100 ng / mL ) for 36 hours and labeled with DIOC 6 ( 3 ) plus HE. MCF7 cells were sorted on a cytofluorometer ( ELITE; Becton Dickinson, Le Pont de Claix, France ) according to their DIOC 6 ( 3 ) profile and recovered on complete medium on ice. Cells were immediately lysed and 13 g of total cell lysates was analysed by immunoblotting, using anti -caspase -8 antibody. One representative experiment out of two is shown. Cancer Gene Therapy p53 and TNF converge on mitochondria M Ameyar -Zazoua et al
We have next investigated the consequences of infection by Adwtp53 on ÁÉ m and mitochondrial generation of ROS. Data depicted in Figure 4C revealed that while Adwtp53 itself had no major effects on the ÁÉ m and on the mitochondrial generation of ROS (Fig 4C ) , infection with Adwtp53 and concomitant TNF treatment resulted in an increased portion of cells with reduced ÁÉ m and increased ROS generation. Again, ZVAD -fmk abolished mitochondrial disruption induced by the combination of Adwtp53 and TNF (Fig 4C ) . Thus, Adwtp53 can restore both caspase -8 activation and mitochondrial alterations induced by TNF.
Adwtp53 infection of cl.1001 cells restores the TNF -induced mitochondrial release of AIF and cytochrome c
In an attempt to confirm the effect of Adwtp53 on mitochondria, we assessed the subcellular localization of two mitochondrial intermembrane proteins. In MCF7 control cells, AIF was found to be localized to mitochondria, unless apoptosis was induced and the AIF staining became diffuse throughout the cell including the nucleus. This mitochondrio -nuclear translocation of AIF was completely abolished by pretreatment with ZVAD -fmk, indicating that a ZVADfmk -inhibitable caspase (presumably caspase -8 ) is necessary for the translocation of AIF (not shown). Similar results were obtained for cytochrome c, which was released from mitochondria when MCF7 cells were exposed to TNF (but not when cells were treated with TNF + ZVAD -fmk, data not shown ). In MCF7 cells, the translocation of AIF or cytochrome c was induced by TNF ( Fig 5 ) , and this phenomenon was not influenced by infection with control adenovirus or Adwtp53. In contrast to TNF -sensitive MCF7 cells, TNF -resistant cl.1001 cells failed to translocate AIF ( Fig 6A ) or cytochrome c (Fig 6B ) in response to TNF. Infection with Adwtp53, which by itself had no effect on the subcellular localization of AIF or cytochrome c, did restore the capacity of TNF to induce the mitochondrial release of both AIF (Fig 6A ) and cytochrome c (Fig 6B ) . As a control, the ''empty'' adenovirus did not restore the AIF / cytochrome c translocation. It thus appears that reintroduction of wtp53 into cl.1001 cells can restore the mitochondrial pathway of TNF -induced apoptosis.
Discussion
TNF is capable of inducing tumor regression comparable to that of chemotherapeutic agents. 41 The cytotoxic effect of this cytokine towards tumor cells can be affected by both intrinsic and acquired cell resistance. Several pieces of evidence indicate that tumor resistance to cytotoxic mechanisms represents an additional strategy employed by tumor cells to escape from specific or nonspecific tumor surveillance. 42 It has become widely accepted that cell surface expression of TNF receptors is necessary but not sufficient to mediate an apoptotic response, and that postreceptor mechanisms are important in controlling susceptibility to the cytotoxic action of TNF. Although considerable progress has been made in identifying gene products that regulate TNF -induced cell death, the current understanding of the molecular mechanisms critical for tumor resistance to the cytotoxic action of this cytokine remains limited. In this Figure 4 Effect of Adwtp53 transfer on mitochondrial collapse and caspase -8 cleavage in TNF -resistant cells. cl.1001 cells were infected for 40 hours with 100, 200 pfu of Adwtp53, or control adenovirus ( EV ) and either incubated with TNF( 100 ng / mL ) and / or ZVAD -fmk ( 100 M ). Pro -caspase -8 cleavage was determined by subjecting cells to Western blot analysis ( 40 g of protein per lane ) using anti -caspase -8 antibody ( C15 ) ( A ). Densitometry scan quantitation in respect to actin level ( B ). ÁÉ m quantification and superoxide anion generation were determined by labeling cells with DIOC 6 ( 3 ) and HE as described above ( C ).
Cancer Gene Therapy p53 and TNF converge on mitochondria M Ameyar -Zazoua et al context, we have reported the existence of an association between resistance to the cytotoxic action of TNF and the loss of p53 function. 30 More recently, we have shown that adenovirus -based transfer of wtp53 gene increased sensitivity of cells with mutant p53 to the cytotoxic effect of TNF 31 by a mechanism independent of Bax and Bcl -2 expression but involving ROS production. 43 In the present study, we further examined the molecular basis of tumor resistance to the cytotoxic action of TNF and explored the wtp53-induced sensitization of TNF -resistant cells to the cytotoxic action of TNF.
It is established that ligand-bound p55 TNF receptor can interact with caspases via the cytoplasmic adaptor proteins TRADD and FADD. 5, 44 Our data indicate that resistance of 1001 cells to the cytotoxic action of TNF was not associated with an alteration in TRADD and FADD expression level. In strict contrast, it appears that caspase -8 activation (but not expression ) is deficient in the 1001 clone. Concomitantly, we observed that all signs of apoptosis -associated mitochondrial membrane permeabilization ( which occur downstream, yet in strong association with the activation of caspase -8 ) failed to become manifest in 1001 cells stimulated with TNF. In parental TNF -sensitive MCF7 cells, TNF treatment resulted in the dissipation of the ÁÉ m , an increase in HE -detectable (presumably mitochondriongenerated ) ROS, the translocation of AIF from mitochondria to the nucleus, and the release of cytochrome c from mitochondria to the cytosol. None of these alterations was observed in TNF -stimulated, TNF -resistant cl.1001 cells.
Reintroduction of wtp53 into 1001 cells ( in which p53 has mutated ) restores the TNF -mediated cytotoxic effect on these cells. 31 Several reports indicate that p53 can induce or potentiate apoptosis through a variety of mechanisms, e.g., by regulating the expression of genes that participate in the apoptotic response at the mitochondrial level, 45 ,46 a transcription -dependent p53 -induced alteration in the redox balance, 47 and /or through transcription -independent effects, 28, 48, 49 which may involve the translocation of p53 to mitochondrial membranes, facilitating their permeabilization. 50 Caspase activation (caspases-3 and -9) has also been connected to p53 -mediated cell death. 51, 52 The interference of p53 with caspase-3 in our cell model is ruled out because MCF7 cells have been reported to be deficient in caspase-3 expression. 53 Here, we demonstrate for the first time that the overexpression of wtp53 restores caspase -8 cleavage in TNF -resistant cells, correlating with a reestablishment of TNF -induced killing. In addition, we demonstrate that wtp53 was able to restore the TNF -induced mitochondrial membrane permeabilization at all levels ( loss of potential, ROS generation, AIF translocation, cytochrome c release ). Bid, which is a proapoptotic member of the Bcl2 family, is directly cleaved by caspase -8 and the C -terminal fragment acts on mitochondria to trigger cytochrome c release. 36 Whether p53 effect involves Bid pathway through caspase-8 has to be determined.
In addition, whether the p53-induced sensitisation to TNF cytotoxic action involves an effect on the recruitment of proapoptotic proteins to TNFR1 and /or more direct mitochondrial effects remains elusive. There is accumulating evidence to suggest that inactivation of the TNF -inducible NF -B transcription factor complex potentiates the cytotoxic action of TNF or genotoxic agents. 54 -56 Indeed, NF -B has a direct transcriptional effect, inducing genes that promote resistance to apoptosis. Recently, it has been shown that both p53 and NF -B inhibit each other's ability to stimulate gene expression and that this process is controlled by the relative levels of each transcription factor. Both p53 and RelA (p65 ) interact with the transcriptional coactivator proteins p300 and CREB -binding protein (CBP ), suggesting that both factors are competing for a limiting pool of p300/CBP. 57 In this regard, it would be of great interest to determine if the overexpression of p53 following adenovi- Cancer Gene Therapy p53 and TNF converge on mitochondria M Ameyar -Zazoua et al rus -mediated transfer results in down -regulation of NF -B -mediated transcriptional activation and the subsequent sensitization of TNF -resistant cells to TNF. This will be the subject of future investigations.
The data reported here are in support of a model in which p53 plays a role in the cross -talk between the apoptosis pathway involving ligation of TNF death receptor, the apoptosome formation, and the mitochondrial pathway involving cytochrome c and AIF release.
The understanding of how DNA damage and p53 engage the death machinery as well as the elucidation of the crosstalk between p53 and components of this machinery is crucial to increase our ability to manipulate apoptosis and to revert human tumors to an apoptosis -sensitive phenotype. In this regard, the delineation of the link among p53, caspases, and mitochondria is of major interest and may provide a variety of molecular targets for restoring apoptosis susceptibility in TNF -resistant cells.
